Company: VEEAW
Filing Date: 2025-08-06
Form Type: S-1/A
Source: 0001213900-25-072342
Chunk: 87

Company: VEEA INC.
Filing Date: 2025-08-06
Form: S-1/A
Chunk 87
---
953 are fully vested and exercisable; |

| ● | 1,248,177 shares available for future issuance under the 
 Company’s 2024 Incentive Award Plan.                     |

| ● | the shares of common stock issuable upon exercise of the Investor Warrants issued in this offering. |

Except as otherwise indicated, the information in this prospectus assumes no exercise of any existing options or exercise of any existing warrants. The discussion and table above assume no exercise of the common warrants. To the extent that the Investor Warrants are exercised, you may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. 46 CAPITALIZATION The following table sets forth our cash and cash equivalents and capitalization as of March 31, 2025:

| ● | on an actual basis; |

| ● | on a pro forma basis to give                                                                             
 effect to 4,471,233 shares of common stock issued subsequent to March 31, 2025, including 4,065,689      
 shares issued along with cash received of $1.0 million for convertible notes issued in connection        
 with the Crowdkeep Transaction; 117,500 shares sold under the ELOC Purchase Agreement for gross proceeds 
 of $232,340, 100,000 shares issued to a service provider to the Company; 26,666 shares to certain        
 directors and officers; 112,665 shares issued to holders of convertible notes issued by the Company      
 in connection with the Business Combination upon conversion of the notes; 34,184 shares issued to        
 certain employees; and 14,529 issued upon exercise of outstanding stock options for net proceeds         
 of $7.26;                                                                                                |

| ● | on a pro forma as adjusted                                                                                
 basis to give further effect to the issuance and sale of 6,206,897 shares of our common stock and         
 accompanying warrants in this offering at an assumed offering price of $1.45 per share, which was         
 the closing price of our common stock as reported on Nasdaq on August 4, 2025, after deducting the        
 placement agent fees and estimated offering expenses payable by us, and assuming no exercise of Warrants. |

Our capitalization following the closing of this offering will